Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Franchini

Showing results (451-460 of 749) with videos related to

Pageof 75
Sort By:
Blood Transfusion = Trasfusione Del Sangue|December 30, 2014
Role of rituximab in the treatment of postpartum acquired haemophilia A: a systematic review of the literatureCarlo Bonfanti, Silvia Crestani, Francesco Frattini, et al.
Cancer Treatment Reviews|April 20, 2007
Lipoprotein[a] and cancer: anti-neoplastic effect besides its cardiovascular potencyGiuseppe Lippi, Massimo Franchini, Gian Luca Salvagno, et al.
Clinical Chemistry and Laboratory Medicine|July 21, 2004
Comparison of serum creatinine, uric acid, albumin and glucose in male professional endurance athletes compared with healthy controlsGiuseppe Lippi, Giorgio Brocco, Massimo Franchini, et al.
Seminars in Thrombosis and Hemostasis|March 25, 2009
Milestones and perspectives in coagulation and hemostasisGiuseppe Lippi, Emmanuel J Favaloro, Massimo Franchini, et al.
Hepatology International|August 12, 2009
The effect of iron depletion on chronic hepatitis C virus infectionMassimo Franchini, Giovanni Targher, Franco Capra, et al.
Biologics : Targets & Therapy|February 23, 2013
Treatment of hemophilia B: focus on recombinant factor IXMassimo Franchini, Francesco Frattini, Silvia Crestani, et al.
Seminars in Thrombosis and Hemostasis|May 6, 2016
Innovative Pharmacological Therapies for the Hemophilias Not Based on Deficient Factor ReplacementPier Mannuccio Mannucci, Maria Elisa Mancuso, Elena Santagostino, et al.
Seminars in Thrombosis and Hemostasis|June 18, 2014
Hemostatic agents for bleeding: recombinant-activated factor VII and beyondMassimo Franchini, Silvia Crestani, Francesco Frattini, et al.
Haematologica|November 5, 2002
Low-dose epirubicin in combination with cyclophosphamide, vinblastine and prednisone (mini-CEOP) for the treatment of aggressive non-Hodgkin's lymphoma in elderly patientsDino Veneri, Flavia Zanetti, Massimo Franchini, et al.
Critical Reviews in Clinical Laboratory Sciences|June 14, 2006
Biochemistry, physiology, and complications of blood doping: facts and speculationGiuseppe Lippi, Massimo Franchini, Gian Luca Salvagno, et al.
Pageof 75

Showing results (451-460 of 749) with videos related to

Sort By:
Pageof 75
Blood Transfusion = Trasfusione Del Sangue|December 30, 2014
Role of rituximab in the treatment of postpartum acquired haemophilia A: a systematic review of the literatureCarlo Bonfanti, Silvia Crestani, Francesco Frattini, et al.
Cancer Treatment Reviews|April 20, 2007
Lipoprotein[a] and cancer: anti-neoplastic effect besides its cardiovascular potencyGiuseppe Lippi, Massimo Franchini, Gian Luca Salvagno, et al.
Clinical Chemistry and Laboratory Medicine|July 21, 2004
Comparison of serum creatinine, uric acid, albumin and glucose in male professional endurance athletes compared with healthy controlsGiuseppe Lippi, Giorgio Brocco, Massimo Franchini, et al.
Seminars in Thrombosis and Hemostasis|March 25, 2009
Milestones and perspectives in coagulation and hemostasisGiuseppe Lippi, Emmanuel J Favaloro, Massimo Franchini, et al.
Hepatology International|August 12, 2009
The effect of iron depletion on chronic hepatitis C virus infectionMassimo Franchini, Giovanni Targher, Franco Capra, et al.
Biologics : Targets & Therapy|February 23, 2013
Treatment of hemophilia B: focus on recombinant factor IXMassimo Franchini, Francesco Frattini, Silvia Crestani, et al.
Seminars in Thrombosis and Hemostasis|May 6, 2016
Innovative Pharmacological Therapies for the Hemophilias Not Based on Deficient Factor ReplacementPier Mannuccio Mannucci, Maria Elisa Mancuso, Elena Santagostino, et al.
Seminars in Thrombosis and Hemostasis|June 18, 2014
Hemostatic agents for bleeding: recombinant-activated factor VII and beyondMassimo Franchini, Silvia Crestani, Francesco Frattini, et al.
Haematologica|November 5, 2002
Low-dose epirubicin in combination with cyclophosphamide, vinblastine and prednisone (mini-CEOP) for the treatment of aggressive non-Hodgkin's lymphoma in elderly patientsDino Veneri, Flavia Zanetti, Massimo Franchini, et al.
Critical Reviews in Clinical Laboratory Sciences|June 14, 2006
Biochemistry, physiology, and complications of blood doping: facts and speculationGiuseppe Lippi, Massimo Franchini, Gian Luca Salvagno, et al.
Pageof 75